期刊文献+

白化病的遗传异质性 被引量:4

Genetic Heterogeneity in Albinism
下载PDF
导出
摘要 白化病(albinism)是由黑色素(melanin)合成相关基因突变导致黑色素沉着减少或缺失引起的一类遗传性疾病的总称。根据临床表现涉及的组织、器官、系统的复杂程度,白化病分为非综合征白化病和综合征性白化病两大类,每一类包括若干病种,而有些病种又可根据基因座的不同区分为若干型,各型都存在一定程度的等位基因遗传异质性。本文主要概述国内外白化病的基因座遗传异质性和眼皮肤白化病的等位基因遗传异质性研究进展,为遗传咨询提供理论依据。 Albinism refers to a group of inherited conditions, Related genes' mutations lead to the melanin decrease or absence. Clinically, basing on the affecting grades of tissues, organs and systems by albinism, it can be firstly divided into two main categories : non - syndromic and syndromic, Each of them includes more than one disorder; some of them can be divided further into several types which are of different loci and variable in allelic heterogeneity. This article mainly reviews the researches on locus heterogeneity and allelie heterogeneity of albinism so as to provide theoretical basis for genetic counseling.
出处 《中国全科医学》 CAS CSCD 2007年第5期416-418,共3页 Chinese General Practice
关键词 白化病 遗传异质性 等位基因遗传异质性 Albinism Genetic heterogeneity Allelic heterogeneity
  • 相关文献

参考文献20

  • 1Resenberg T,Schwartz M.X-linked ocular albinism:prevalence and mutations--a national study[J].Eur J Hum Genet,1998,6:570-577.
  • 2Bassi MT,Incerti B,Easty DJ,et al.Cloning of the murine homolog of the ocular albinism type 1 (OA1) gene:sequence,genomic structure,and expression analysis in pigment cells[J].Genome Res,1996,6:880-885.
  • 3李洪义,魏海云,吴维青,郑辉.眼皮肤白化病的临床表现与危害[J].中国全科医学,2006,9(14):1211-1212. 被引量:11
  • 4Ito S,Suzuki T,Inagaki K,et al.High frequency of hermansky-pudlak syndrome type 1 (HPS1) among japanese albinism patients and functional analysis of HPS1 mutant protein[J].J Invest Dermatol,2005,125:715-720.
  • 5Griffin AE,Cobb BR,Anderson PD,et al.Detection of hemizygosity in Hermansky Pudlak syndrome by quantitative real-time PCR[J].Clin Genet,2005,68:23-30.
  • 6Morgan NV,Pasha S,Johnson CA,et al.A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8)[J].Am J Hum Genet,2006,78:160-166.
  • 7Zarzour W,Kleta R,Frangoul H,et al.Two novel CHS1 (LYST) mutations:clinical correlations in an infant with Chediak-Higashi syndrome[J].Mol Genet Metab,2005,85:125-132.
  • 8Malhotra AK,Bhaskar G,Nanda M,et al.Griscelli syndrome[J].J Am Acad Dermatol,2006,55:337-340.
  • 9Vastinsalo H,Isosomppi J,Aittakorpi A,et al.Two Finnish USH1B patients with three novel mutations in myosin VIIA[J].Mol Vis,2006,12:1093-1097.
  • 10Giebel LB,Strunk KM,Spritz RA.Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment[J].Genomics,1991,9:435-445.

二级参考文献30

  • 1李洪义,曾瑞萍,杜传书.用一对错配引物进行的PCR/酶解法检测β-地中海贫血-28(A→G)突变[J].中山大学学报(医学科学版),1993,14(4). 被引量:2
  • 2魏海云,李洪义,郭向明,郑辉.白化病的眼表现及其发生机制[J].中国实用眼科杂志,2005,23(7):653-656. 被引量:18
  • 3段红蕾,郑辉,李洪义.眼皮肤白化病Ⅱ型相关的P基因突变与DNA多态性[J].遗传,2005,27(6):984-988. 被引量:7
  • 4Oetting WS, King RA. Molecular Basis of Albinism: Mutations and Polymorphisms of Pigmentation Genes Associated With Albinism[J]. Hum Murat, 1999, 13 (2): 99-115.
  • 5Biswas S, Lloyd ZC. Oculocutaneous albinism[J]. Arch Dis Child, 1999, 80:565 -569.
  • 6Rosenmann E, Rosenmann A, Ne'eman Z,et al. Prenatal diagnosis of oculocutaneous albinism type 1 : review and personal experience[J]. Pedia and dev pathol, 1999, 2:404-414.
  • 7Oetting WS, Fryer JP, Shriram S, et al. Oculocutaneous albinism type 1: the last 100 years [J]. Pigment cell res, 2003, 16:307-311.
  • 8Knuth H. Eye deficits in albinism [ J ]. J Ophthalmic Nurs Technol, 1991, 10 ( 2 ) :55 - 62.
  • 9Sjodell L, Sjostrom A, Abrahamsson M.Transinumination of iris and subnormal vusual acuity - Ocular Albinism [ J ] ? Br J Ophthalmol, 1996, 80:617-623.
  • 10Meyer CH, Lapolice D J, Freedman SF. Foveal hypoplasia in Oculocutaneous albinism demonstrated by optical coherencetomography[J]. Am J Opthalmol, 2002, 133:409 -410.

共引文献14

同被引文献39

  • 1谢正德,段红梅,张辉,闫静,刘亚谊,申昆玲.儿童EB病毒相关性噬血淋巴组织细胞增生症的病毒学特征[J].首都医科大学学报,2005,26(5):568-570. 被引量:6
  • 2毛一雷.多器官功能障碍综合征和SIRS[J].中国实用外科杂志,2006,26(12):921-923. 被引量:3
  • 3RouphaeI NG, Talati NJ, Vaughan C,et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis, 2007,7 (12): 814-822.
  • 4Henter JI. Biology and treatment of familial hemophagocytic lymphohistioeytosis: importance of perforin in lymphocyte-mediated cytotoxieity and triggering of apoptosis. Med Pediatr Oncol, 2002,38 (3) : 305-309.
  • 5Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med,2006,38(1) :20-31.
  • 6Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991,18(1):29-33.
  • 7Henter J-I, Horne AC, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer,2007,48(2):124-131.
  • 8Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics, 2006, 117 (4) : e743-750.
  • 9Cesaro S, Locatelli F, Lanino E, et al. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology(AIEOP). Haematologica, 2008,93 ( 11 ) : 1694-1701.
  • 10Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization Classification of neoplastic disease of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee Meeting, Airlie Housr, Virginia, November, 1997. Hematol J, 2000, 1(1) : 53-66.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部